8247 — BioSino Bio-technology and Science Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$81.04m
- HK$219.36m
- CNY373.07m
- 17
- 58
- 10
- 14
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -14.5 | -115 | 2.15 | 6.41 | 18.5 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 13.1 | 129 | -10.1 | 22 | 5.26 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -18.8 | -16.5 | -6.01 | -7.41 | -2.97 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4.48 | 31.4 | 11.4 | 48.9 | 44.5 |
Capital Expenditures | -41 | -18.3 | -16 | -6.55 | -16.5 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 6.17 | 69.6 | 0.015 | 0.771 | 15.4 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -34.9 | 51.3 | -15.9 | -5.78 | -1.12 |
Financing Cash Flow Items | -3.52 | -15.8 | -11.8 | -10.6 | 14.9 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 22 | -71.1 | 20.5 | -44 | -10.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8.55 | 11.8 | 15.4 | -0.984 | 32.9 |